Loading…
Based on limited metadata, Effingham Equity received an FDA Warning Letter on September 20, 2022, regarding animal and veterinary products. Without access to the full letter text or specific subject line details, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's animal and veterinary product regulatory authority, though the specific issuing office is not identified in this metadata. To understand the particular compliance issues cited, the complete Warning Letter would need to be reviewed.